Discounted Cash Flow Rating

Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Buy

AptarGroup, Inc. (ATR)

Plastics Products, Nec

https://www.aptar.com

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.

265 EXCHANGE DRIVE, SUITE 301
CRYSTAL LAKE, IL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/01/1993

Market Cap

9,699,345,240

Shares Outstanding

65,780,000

Weighted SO

65,781,269

Total Employees

N/A

Upcoming Earnings

07/25/2024

Similar Tickers

Beta

0.5650

Last Div

1.8000

Range

120.36-151.73

Chg

-0.9100

Avg Vol

268291

Mkt Cap

9699345240

Exch

NYSE

Country

Phone

815 477 0424

DCF Diff

6.0889

DCF

140.9211

Div Yield

0.0115

P/S

2.7268

EV Multiple

14.1814

P/FV

4.0427

Div Yield %

1.1499

P/E

30.2558

PEG

5.8978

Payout

0.3377

Current Ratio

1.3643

Quick Ratio

0.9494

Cash Ratio

0.1896

DSO

77.1199

DIO

74.5572

Op Cycle

151.6772

DPO

104.8895

CCC

46.7877

Gross Margin

0.3330

Op Margin

0.1267

Pretax Margin

0.1162

Net Margin

0.0900

Eff Tax Rate

0.2258

ROA

0.0719

ROE

0.1384

ROCE

0.1372

NI/EBT

0.7749

EBT/EBIT

0.9167

EBIT/Rev

0.1267

Debt Ratio

0.2441

D/E

0.4537

LT Debt/Cap

0.2214

Total Debt/Cap

0.3121

Int Coverage

21.8670

CF/Debt

0.5785

Equity Multi

1.8583

Rec Turnover

4.7329

Pay Turnover

3.4799

Inv Turnover

4.8956

FA Turnover

2.3323

Asset Turnover

0.7987

OCF/Share

9.4847

FCF/Share

4.8708

Cash/Share

3.3763

OCF/Sales

0.1768

FCF/OCF

0.5135

CF Coverage

0.5785

ST Coverage

1.5502

CapEx Coverage

2.0557

Div&CapEx Cov

1.5189

P/BV

4.0427

P/B

4.0427

P/S

2.7268

P/E

30.2558

P/FCF

30.0296

P/OCF

15.4037

P/CF

15.4037

PEG

5.8978

P/S

2.7268

EV Multiple

14.1814

P/FV

4.0427

DPS

1.6800

Latest Headlines (EST)

GlobeNewswire Inc. Feb 25, 00:30 Aerosol Valves Market to Reach USD 3.6 billion, Globally, by 2035 at 5.2% CAGR: Future Market Insights, Inc. ATR GlobeNewswire Inc. Jan 30, 22:39 Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws ATRA GlobeNewswire Inc. Nov 20, 21:47 FUJIFILM Diosynth Biotechnologies Celebrates the Expansion Completion at its California Cell Therapy Facility ATRA GlobeNewswire Inc. Aug 21, 00:30 Global Cosmetic Droppers Market Projected to Reach USD 132.3 Million by 2034, Driven by Strong Demand for Glass Droppers | Future Market Insights, Inc. ATR Seeking Alpha Jan 05, 01:26 Atlanta Braves: This Yankees Fan Is A Buyer MSGS, MANU, BATRK, BATRA Seeking Alpha Jan 05, 01:26 Atlanta Braves: This Yankees Fan Is A Buyer MSGS, MANU, BATRK, BATRA GlobeNewswire Inc. Dec 19, 08:30 Natureâ€™s Sunshine Recognized with Best Company Culture Award NATR Seeking Alpha Nov 27, 00:43 Dividend Champion, Contender, And Challenger Highlights: Week Of November 26 ABR, ADC, ADI, AEM, AFL, +186 more Zacks Investment Research Nov 24, 12:29 Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why ACAD, ATRA, ANAB, ALLO PennyStocks Nov 22, 15:14 Penny Stocks To Buy Under $1? 3 For Your Holiday Watch List ATRA, OBLG, SEEL PennyStocks Nov 17, 13:32 11 Top Penny Stocks To Buy Now According To Insiders ATRA, BLDE, FBIO, GRWG, IHRT, +4 more PennyStocks Nov 17, 13:32 11 Top Penny Stocks To Buy Now According To Insiders ATRA, BLDE, FBIO, GRWG, IHRT, +4 more PennyStocks Nov 15, 12:52 5 Penny Stocks To Buy Now According To Insiders ATRA, BLDE, FTCI, GOSS, PCT PennyStocks Nov 15, 12:52 5 Penny Stocks To Buy Now According To Insiders ATRA, BLDE, FTCI, GOSS, PCT MarketWatch Nov 15, 10:20 Hedge-fund manager Harris Kupperman who called last yearâ€™s tech crash bets on Florida, oil drillers and this commodity VAL, TDW, DO, JOE, COMP, +25 more GlobeNewswire Inc. Nov 13, 12:18 Atrion Corporation Declares Quarterly Cash Dividend ATRI Benzinga Nov 10, 11:00 Where Atara Biotherapeutics Stands With Analysts ATRA GlobeNewswire Inc. Nov 07, 16:30 Atrion Reports Third Quarter 2023 Results ATRI

Revenue Product Segmentation

Dividend History

Cash Value	Ex-Dividend Date	Declaration Date	Record Date	Pay Date
0.45	07/25/2024	07/11/2024	07/25/2024	08/15/2024
0.41	04/24/2024	04/11/2024	04/25/2024	05/16/2024
0.41	01/31/2024	01/18/2024	02/01/2024	02/22/2024
0.41	10/25/2023	10/12/2023	10/26/2023	11/16/2023
0.41	07/26/2023	07/13/2023	07/27/2023	08/17/2023
0.38	05/03/2023	04/20/2023	05/04/2023	05/25/2023
0.38	02/01/2023	01/19/2023	02/02/2023	02/23/2023
0.38	10/25/2022	10/13/2022	10/26/2022	11/16/2022
0.38	07/26/2022	07/13/2022	07/27/2022	08/17/2022
0.38	04/26/2022	04/14/2022	04/27/2022	05/18/2022
0.38	02/02/2022	01/20/2022	02/03/2022	02/23/2022
0.38	10/26/2021	10/14/2021	10/27/2021	11/17/2021
0.38	08/03/2021	07/22/2021	08/04/2021	08/25/2021
0.38	04/27/2021	04/15/2021	04/28/2021	05/19/2021
0.36	01/26/2021	01/14/2021	01/27/2021	02/17/2021
0.36	10/27/2020	10/15/2020	10/28/2020	11/18/2020
0.36	07/28/2020	07/16/2020	07/29/2020	08/19/2020
0.36	04/28/2020	04/15/2020	04/29/2020	05/20/2020
0.36	01/28/2020	01/16/2020	01/29/2020	02/19/2020
0.36	10/29/2019	10/17/2019	10/30/2019	11/20/2019
0.36	07/30/2019	07/17/2019	07/31/2019	08/21/2019
0.36	04/30/2019	04/18/2019	05/01/2019	05/22/2019
0.34	01/29/2019	01/17/2019	01/30/2019	02/20/2019
0.34	10/30/2018	10/18/2018	10/31/2018	11/21/2018
0.34	07/31/2018	07/18/2018	08/01/2018	08/22/2018
0.32	05/08/2018	04/25/2018	05/09/2018	05/30/2018
0.32	01/30/2018	01/18/2018	01/31/2018	02/21/2018
0.32	10/31/2017	10/19/2017	11/01/2017	11/22/2017
0.32	07/24/2017	07/14/2017	07/26/2017	08/16/2017
0.32	05/01/2017	04/21/2017	05/03/2017	05/24/2017
0.32	01/30/2017	01/20/2017	02/01/2017	02/22/2017
0.32	10/31/2016	10/21/2016	11/02/2016	11/23/2016
0.30	07/25/2016	07/14/2016	07/27/2016	08/17/2016
0.30	04/25/2016	04/15/2016	04/27/2016	05/18/2016
0.30	01/25/2016	01/15/2016	01/27/2016	02/17/2016
0.30	11/02/2015	10/23/2015	11/04/2015	11/25/2015
0.28	07/27/2015	07/17/2015	07/29/2015	08/19/2015
0.28	04/27/2015	04/20/2015	04/29/2015	05/20/2015
0.28	01/26/2015	01/16/2015	01/28/2015	02/18/2015
0.28	11/03/2014	10/24/2014	11/05/2014	11/26/2014
0.28	07/28/2014	07/18/2014	07/30/2014	08/20/2014
0.28	04/28/2014	04/11/2014	04/30/2014	05/21/2014
0.25	01/27/2014	01/17/2014	01/29/2014	02/19/2014
0.25	11/04/2013	10/24/2013	11/06/2013	11/27/2013
0.25	07/29/2013	07/18/2013	07/31/2013	08/21/2013
0.25	04/24/2013	04/11/2013	04/26/2013	05/17/2013
0.25	01/28/2013	01/18/2013	01/30/2013	02/20/2013
0.22	11/05/2012	10/26/2012	11/07/2012	11/28/2012
0.22	08/07/2012	07/27/2012	08/09/2012	08/30/2012
0.22	04/24/2012	04/13/2012	04/26/2012	05/17/2012
0.22	01/30/2012	01/13/2012	02/01/2012	02/22/2012
0.22	11/07/2011	10/20/2011	11/09/2011	11/30/2011
0.22	07/29/2011	07/21/2011	08/02/2011	08/23/2011
0.18	04/25/2011	04/19/2011	04/27/2011	05/18/2011
0.18	01/31/2011	01/14/2011	02/02/2011	02/23/2011
0.18	11/01/2010	10/21/2010	11/03/2010	11/24/2010
0.18	07/30/2010	07/22/2010	08/03/2010	08/24/2010
0.15	04/26/2010	04/16/2010	04/28/2010	05/19/2010
0.15	02/01/2010	01/22/2010	02/03/2010	02/24/2010
0.15	10/26/2009	10/15/2009	10/28/2009	11/18/2009
0.15	07/27/2009	07/20/2009	07/29/2009	08/19/2009
0.15	04/27/2009	04/15/2009	04/29/2009	05/20/2009
0.15	01/27/2009	01/15/2009	01/29/2009	02/19/2009
0.15	10/27/2008	10/15/2008	10/29/2008	11/19/2008
0.15	07/28/2008	07/17/2008	07/30/2008	08/20/2008
0.13	04/28/2008	04/16/2008	04/30/2008	05/21/2008
0.13	01/29/2008	01/17/2008	01/31/2008	02/21/2008
0.13	10/29/2007	10/17/2007	10/31/2007	11/21/2007
0.13	07/27/2007	07/18/2007	07/31/2007	08/21/2007
0.26	04/30/2007	04/18/2007	05/02/2007	05/23/2007
0.22	01/29/2007	01/18/2007	01/31/2007	02/22/2007
0.22	10/30/2006	10/18/2006	11/01/2006	11/22/2006
0.22	07/28/2006	07/19/2006	08/01/2006	08/22/2006
0.20	04/26/2006	04/20/2006	04/28/2006	05/19/2006
0.20	01/30/2006	01/19/2006	02/01/2006	02/23/2006
0.20	10/31/2005	10/19/2005	11/02/2005	11/23/2005
0.20	07/29/2005	07/21/2005	08/02/2005	08/23/2005
0.15	04/27/2005	04/15/2005	04/29/2005	05/20/2005
0.15	01/31/2005	01/20/2005	02/02/2005	02/24/2005
0.15	10/26/2004	10/14/2004	10/28/2004	11/18/2004
0.15	07/23/2004	07/19/2004	07/27/2004	08/17/2004
0.07	04/28/2004	04/19/2004	04/30/2004	05/21/2004
0.07	02/02/2004	01/20/2004	02/04/2004	02/26/2004
0.07	10/27/2003	10/17/2003	10/29/2003	11/19/2003
0.07	07/25/2003	07/18/2003	07/29/2003	08/19/2003
0.06	04/29/2003	04/16/2003	05/01/2003	05/22/2003
0.06	02/03/2003	01/21/2003	02/05/2003	02/27/2003
0.06	10/28/2002	10/21/2002	10/30/2002	11/20/2002
0.06	07/26/2002	07/22/2002	07/30/2002	08/20/2002
0.06	04/29/2002	04/22/2002	05/01/2002	05/22/2002
0.06	02/04/2002	01/22/2002	02/06/2002	02/28/2002
0.06	10/29/2001	10/22/2001	10/31/2001	11/21/2001
0.06	07/27/2001	07/25/2001	07/31/2001	08/21/2001
0.05	04/30/2001	04/19/2001	05/02/2001	05/23/2001
0.05	02/05/2001	01/23/2001	02/07/2001	03/01/2001
0.05	10/30/2000	10/20/2000	11/01/2000	11/22/2000
0.05	07/28/2000	07/20/2000	08/01/2000	08/22/2000
0.05	05/01/2000	04/19/2000	05/03/2000	05/24/2000
0.05	02/07/2000	01/27/2000	02/09/2000	03/02/2000
0.05	10/29/1999	11/30/-0001	11/02/1999	11/23/1999
0.05	07/30/1999	07/22/1999	08/03/1999	08/24/1999
0.04	05/03/1999	04/21/1999	05/05/1999	05/26/1999
0.04	02/01/1999	01/21/1999	02/03/1999	02/25/1999
0.04	10/30/1998	10/23/1998	11/03/1998	11/24/1998
0.08	07/31/1998	07/23/1998	08/04/1998	08/25/1998
0.08	05/04/1998	04/23/1998	05/06/1998	05/27/1998
0.08	02/02/1998	01/22/1998	02/04/1998	02/26/1998
0.08	10/31/1997	10/23/1997	11/04/1997	11/25/1997
0.08	08/01/1997	07/24/1997	08/05/1997	08/26/1997
0.07	05/05/1997	04/24/1997	05/07/1997	05/28/1997
0.07	02/03/1997	01/23/1997	02/05/1997	02/27/1997
0.07	11/01/1996	10/24/1996	11/05/1996	11/26/1996
0.07	08/02/1996	07/24/1996	08/06/1996	08/27/1996
0.07	05/06/1996	04/25/1996	05/08/1996	05/29/1996
0.07	02/05/1996	01/24/1996	02/07/1996	02/29/1996
0.07	11/03/1995	10/25/1995	11/07/1995	11/28/1995
0.07	08/04/1995	07/31/1995	08/08/1995	08/29/1995
0.06	05/04/1995	04/27/1995	05/10/1995	05/31/1995
0.06	02/02/1995	11/30/-0001	02/08/1995	02/28/1995
0.06	11/02/1994	11/30/-0001	11/08/1994	11/29/1994
0.06	08/02/1994	11/30/-0001	08/08/1994	08/29/1994
0.06	05/04/1994	11/30/-0001	05/10/1994	05/31/1994
0.05	02/03/1994	11/30/-0001	02/09/1994	03/01/1994
0.05	11/03/1993	11/30/-0001	11/09/1993	11/30/1993
0.05	08/03/1993	11/30/-0001	08/09/1993	08/30/1993

Year	Purchases	Sales	Total Bought	Total Sold

Transaction Date	Name	Type Of Owner	Price	Securities Owned	Securities Transacted	Security Name	Transaction Type

Less Than 3 Months

251.15K Shares Bought (67.04 %)

123.50K Shares Sold (32.96%)

3 - 6 Months

14.08K Shares Bought (71.66 %)

5.57K Shares Sold (28.34%)

6 - 9 Months

35.50K Shares Bought (29.98 %)

82.92K Shares Sold (70.02%)

9 - 12 Months

0.00 Shares Bought (0 %)

0.00 Shares Sold (0 %)

Investor Name	Investment Discretion	Type of Security	Shares Owned	Avg Price Paid	Market Value	Change In Market Value	Change In Market Value (%)	Ownership	Weight

Date	Investors Holding	Closed Positions	Increased Positions	Reduced Positions	New Positions	Total Invested	Put/Call Ratio	Total Calls	Total Puts

Owner	Shares Owned

	2019	2020	2021	2022	2023	2024	2024
Revenue	685.03M	▼ 671.33M	▲ 749.33M	▲ 813.99M	▼ 795.91M	▲ 838.48M	▲ 915.45M
Cost Of Revenue	457.52M	▼ 435.59M	▲ 470.19M	▲ 521.70M	▼ 520.30M	▲ 526.23M	▲ 647.11M
Gross Profit	227.51M	▲ 235.75M	▲ 279.14M	▲ 292.30M	▼ 275.62M	▲ 312.25M	▼ 268.34M
Gross Profit Ratio	0.33	▲ 0.35	▲ 0.37	▼ 0.36	▼ 0.35	▲ 0.37	▼ 0.29
Research And Development Expenses	75.30M	▲ 82.80M	▲ 140.05M	140.05M	▼ 127.91M	▲ 138.30M	▲ 152.78M
General And Administrative Expenses	106.81M	▲ 108.09M	▼ 0.00	0.00	0.00	0.00	0.00
Selling And Marketing Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling General And Administrative Expenses	106.81M	▲ 108.09M	▲ 128.82M	▲ 140.05M	▼ 127.91M	▲ 138.30M	▲ 152.78M
Other Expenses	9.92M	▼ 1.41M	▼ -1.24M	▲ 60.35M	▼ -69.02M	▲ 4.55M	▼ -859.00K
Operating Expenses	155.42M	▲ 158.07M	▲ 186.71M	▲ 200.40M	▼ 186.80M	▲ 202.68M	▼ 152.78M
Cost And Expenses	612.94M	▼ 593.66M	▲ 656.90M	▲ 722.09M	▼ 707.10M	▲ 728.90M	▲ 799.89M
Interest Income	750.00K	▼ 436.00K	▼ 359.00K	▲ 2.26M	▼ 671.00K	▲ 2.11M	▲ 2.90M
Interest Expense	7.87M	▲ 8.62M	▼ 7.27M	▲ 7.68M	▲ 10.16M	▲ 10.52M	▼ 10.18M
Depreciation And Amortization	48.61M	▲ 49.98M	▲ 57.89M	▲ 66.77M	▼ 62.16M	▲ 64.38M	▼ 64.35M
Ebitda	131.28M	▼ 129.48M	▲ 149.38M	▲ 154.20M	▼ 147.37M	▲ 181.33M	▼ 179.91M
Ebitda Ratio	0.19	▲ 0.19	▲ 0.20	▼ 0.19	▼ 0.19	▲ 0.22	▼ 0.20
Operating Income	56.26M	▲ 74.49M	▲ 81.52M	▲ 87.43M	▼ 85.21M	▼ 84.20M	▲ 115.56M
Operating Income Ratio	0.08	▲ 0.11	▼ 0.11	▼ 0.11	▼ 0.11	▼ 0.10	▲ 0.13
Total Other Income Expenses Net	-6.00M	▲ -1.80M	▼ -12.21M	▲ -7.19M	▼ -11.52M	▼ -20.54M	▲ -11.25M
Income Before Tax	58.96M	▲ 67.70M	▲ 73.31M	▲ 80.24M	▼ 73.69M	▲ 80.63M	▲ 104.32M
Income Before Tax Ratio	0.09	▲ 0.10	▼ 0.10	▲ 0.10	▼ 0.09	▲ 0.10	▲ 0.11
Income Tax Expense	18.29M	▲ 19.16M	▲ 20.07M	▲ 22.71M	▼ 14.30M	▲ 18.38M	▲ 21.39M
Net Income	40.67M	▲ 48.53M	▲ 53.23M	▲ 57.61M	▲ 59.00M	▲ 62.36M	▲ 83.10M
Net Income Ratio	0.06	▲ 0.07	▼ 0.07	▼ 0.07	▲ 0.07	▲ 0.07	▲ 0.09
Eps	0.65	▲ 0.76	▲ 0.82	▲ 0.88	▲ 0.90	▲ 0.95	▲ 1.26
Eps Diluted	0.62	▲ 0.73	▲ 0.79	▲ 0.85	▲ 0.89	▲ 0.93	▲ 1.23
Weighted Average Shs Out	62.83M	▲ 63.84M	▲ 64.83M	▲ 65.70M	▼ 65.27M	▲ 65.81M	▲ 66.06M
Weighted Average Shs Out Dil	65.34M	▲ 66.19M	▲ 67.27M	▲ 67.43M	▼ 66.44M	▲ 67.13M	▲ 67.43M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View

	2019	2020	2021	2022	2023	2024	2024
Cash And Cash Equivalents	261.82M	▼ 241.97M	▲ 300.14M	▼ 122.93M	▲ 141.73M	▲ 223.64M	▼ 199.83M
Short Term Investments	0.00	0.00	▲ 243.00K	▲ 740.00K	▲ 89.42M	▼ 0.00	▲ 1.22M
Cash And Short Term Investments	261.82M	▼ 241.97M	▲ 300.38M	▼ 123.67M	▲ 141.73M	▲ 223.64M	▼ 201.06M
Net Receivables	569.63M	▼ 558.43M	▲ 566.62M	▲ 671.35M	▲ 676.99M	▲ 677.82M	▲ 740.58M
Inventory	381.11M	▼ 375.80M	▲ 379.38M	▲ 441.46M	▲ 486.81M	▲ 513.05M	▼ 496.84M
Other Current Assets	118.25M	▼ 115.05M	▲ 122.61M	▼ 121.73M	▲ 124.77M	▲ 134.76M	▼ 121.54M
Total Current Assets	1.33B	▼ 1.29B	▲ 1.37B	▼ 1.36B	▲ 1.43B	▲ 1.55B	▲ 1.56B
Property Plant Equipment Net	991.61M	▲ 1.09B	▲ 1.20B	▲ 1.28B	▲ 1.34B	▲ 1.54B	▼ 1.52B
Goodwill	712.10M	▲ 763.46M	▲ 898.52M	▲ 974.16M	▼ 945.63M	▲ 963.42M	▼ 953.26M
Intangible Assets	254.90M	▲ 291.08M	▲ 344.31M	▲ 362.34M	▼ 315.74M	▼ 283.21M	▼ 269.43M
Goodwill And Intangible Assets	712.10M	▲ 763.46M	▲ 898.52M	▲ 974.16M	▼ 945.63M	▲ 1.25B	▼ 1.22B
Long Term Investments	25.45M	▼ 8.40M	▲ 50.09M	▲ 59.49M	▼ 52.31M	▼ 49.20M	▼ 48.91M
Tax Assets	38.44M	▲ 41.39M	▼ 37.24M	▼ 27.55M	▼ 20.56M	▼ 0.00	▲ 17.01M
Other Non Current Assets	279.33M	▲ 369.96M	▲ 436.46M	▲ 446.09M	▼ 411.00M	▼ 69.64M	▼ 64.87M
Total Non Current Assets	2.05B	▲ 2.27B	▲ 2.62B	▲ 2.78B	▼ 2.77B	▲ 2.90B	▼ 2.88B
Other Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	3.38B	▲ 3.56B	▲ 3.99B	▲ 4.14B	▲ 4.20B	▲ 4.45B	▼ 4.44B
Account Payables	164.53M	▲ 192.74M	▲ 243.74M	▲ 285.26M	▲ 320.28M	▲ 328.57M	▲ 679.11M
Short Term Debt	163.97M	▼ 110.25M	▲ 117.87M	▲ 289.63M	▼ 122.79M	▲ 458.22M	▼ 435.36M
Tax Payables	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Revenue	67.78M	▲ 86.82M	▲ 87.05M	▼ 86.95M	▼ 80.11M	▼ 60.51M	▲ 62.88M
Other Current Liabilities	292.90M	▲ 293.47M	▲ 331.67M	▼ 320.65M	▲ 393.99M	▲ 404.01M	▼ 18.79M
Total Current Liabilities	689.17M	▼ 683.28M	▲ 780.33M	▲ 982.49M	▼ 917.18M	▲ 1.25B	▼ 1.20B
Long Term Debt	1.13B	▼ 1.09B	▼ 1.05B	▼ 907.02M	▲ 1.05B	▼ 726.46M	▼ 680.36M
Deferred Revenue Non Current	0.00	0.00	▲ 52.21M	▼ 48.01M	▼ 25.36M	▲ 62.80M	▼ 42.46M
Deferred Tax Liabilities Non Current	53.92M	▼ 41.39M	▼ 37.24M	▼ 27.55M	▼ 20.56M	▼ 19.02M	▼ 17.01M
Other Non Current Liabilities	85.78M	▲ 179.75M	▲ 214.49M	▼ 191.69M	▼ 119.56M	▼ 71.02M	▲ 138.19M
Total Non Current Liabilities	1.27B	▲ 1.31B	▲ 1.36B	▼ 1.17B	▲ 1.22B	▼ 879.28M	▼ 878.01M
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital Lease Obligations	8.35M	▲ 55.28M	▼ 52.21M	▼ 51.75M	▼ 42.95M	▲ 45.27M	▼ 43.60M
Total Liabilities	1.95B	▲ 1.99B	▲ 2.14B	▲ 2.16B	▼ 2.14B	▼ 2.13B	▼ 2.07B
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Stock	673.00K	▲ 686.00K	▲ 695.00K	▲ 704.00K	▲ 709.00K	▲ 717.00K	▲ 720.00K
Retained Earnings	1.37B	▲ 1.52B	▲ 1.64B	▲ 1.79B	▲ 1.93B	▲ 2.11B	▲ 2.17B
Accumulated Other Comprehensive Income Loss	-310.50M	▼ -341.95M	▲ -281.71M	▼ -316.04M	▼ -341.37M	▲ -308.73M	▼ -347.42M
Other Total Stockholders Equity	360.56M	▲ 389.36M	▲ 487.58M	▲ 495.33M	▼ 465.35M	▲ 505.03M	▲ 529.70M
Total Stockholders Equity	1.42B	▲ 1.57B	▲ 1.85B	▲ 1.97B	▲ 2.05B	▲ 2.31B	▲ 2.35B
Total Equity	1.42B	▲ 1.57B	▲ 1.85B	▲ 1.98B	▲ 2.07B	▲ 2.32B	▲ 2.36B
Total Liabilities And Stockholders Equity	3.38B	▲ 3.56B	▲ 3.99B	▲ 4.14B	▲ 4.20B	▲ 4.45B	▼ 4.44B
Minority Interest	315.00K	▲ 336.00K	▲ 396.00K	▲ 15.19M	▼ 14.27M	▲ 14.47M	▼ 14.07M
Total Liabilities And Total Equity	3.38B	▲ 3.56B	▲ 3.99B	▲ 4.14B	▲ 4.20B	▲ 4.45B	▼ 4.44B
Total Investments	25.45M	▼ 8.40M	▲ 50.33M	▲ 60.23M	▲ 141.73M	▼ 49.20M	▲ 50.13M
Total Debt	1.29B	▼ 1.20B	▼ 1.17B	▲ 1.20B	▼ 1.18B	▲ 1.18B	▼ 1.16B
Net Debt	1.03B	▼ 953.73M	▼ 872.73M	▲ 1.07B	▼ 1.03B	▼ 961.03M	▼ 959.48M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View

	2019	2020	2021	2022	2023	2024	2024
Net Income	40.68M	▲ 48.54M	▲ 53.25M	▲ 57.53M	▲ 59.39M	▲ 62.25M	▲ 83.10M
Depreciation And Amortization	48.61M	▲ 49.98M	▲ 57.89M	▲ 60.35M	▼ 58.89M	▲ 64.38M	▼ 64.35M
Deferred Income Tax	-17.94M	▲ 2.80M	▼ -5.61M	▲ -3.43M	▲ -2.60M	▼ -2.91M	▼ -7.96M
Stock Based Compensation	4.73M	▲ 5.82M	▲ 7.96M	▲ 9.15M	▼ 9.00M	▼ 5.21M	▲ 18.28M
Change In Working Capital	28.38M	▼ 23.21M	▲ 67.69M	▼ -29.50M	▲ 47.10M	▲ 82.40M	▼ -68.17M
Accounts Receivables	1.35M	▲ 15.33M	▲ 56.95M	▼ -9.47M	▲ 61.09M	▲ 74.26M	▼ -56.53M
Inventory	16.00M	▲ 16.63M	▼ 9.79M	▼ -8.48M	▲ 1.79M	▼ -5.45M	▲ 7.27M
Accounts Payables	-18.77M	▲ -15.83M	▲ 1.48M	▼ -11.42M	▲ -6.96M	▲ 10.74M	▼ 4.71M
Other Working Capital	29.80M	▼ 7.07M	▼ -531.00K	▲ -137.00K	▼ -8.82M	▲ 2.86M	▼ -23.62M
Other Non Cash Items	-424.00K	▲ 3.74M	▲ 7.56M	▲ 9.97M	▼ 493.00K	▲ 8.31M	▲ 194.26M
Net Cash Provided By Operating Activities	104.04M	▲ 134.08M	▲ 188.73M	▼ 104.07M	▲ 172.27M	▲ 219.64M	▼ 92.33M
Investments In Property Plant And Equipment	-66.20M	▲ -55.62M	▼ -74.99M	▼ -91.25M	▲ -84.30M	▲ -83.56M	▲ -75.66M
Acquisitions Net	10.00M	▼ -57.27M	▲ 0.00	▼ -23.42M	▲ -685.00K	▼ -689.00K	▲ 175.00K
Purchases Of Investments	-10.00M	▲ 0.00	▼ -1.42M	▼ -1.42M	▲ 0.00	0.00	▼ -1.07M
Sales Maturities Of Investments	66.20M	▼ 0.00	0.00	▲ 2.75M	▼ 0.00	0.00	0.00
Other Investing Activities	-66.78M	▲ 616.00K	▲ 2.32M	▼ -469.00K	▲ 11.74M	▼ -881.00K	▲ -20.00K
Net Cash Used For Investing Activities	-66.78M	▼ -112.27M	▲ -74.09M	▼ -113.81M	▲ -73.24M	▼ -85.13M	▲ -76.57M
Debt Repayment	-28.86M	▲ -14.48M	▲ -4.84M	▲ -4.82M	▼ -8.26M	▼ -9.30M	▼ -18.95M
Common Stock Issued	0.00	0.00	0.00	▲ 5.93M	▲ 10.10M	▲ 14.24M	▲ 22.34M
Common Stock Repurchased	1.00K	▼ -31.62M	▲ 0.00	▼ -49.75M	▲ -19.80M	▲ -10.25M	▼ -12.08M
Dividends Paid	-21.36M	▼ -23.01M	▼ -23.30M	▼ -25.02M	▲ -24.81M	▼ -26.97M	▼ -27.06M
Other Financing Activities	-14.93M	▲ 18.14M	▼ -18.86M	▲ 96.94M	▼ -39.23M	▼ -45.26M	▲ 104.68M
Net Cash Used Provided By Financing Activities	-65.15M	▲ -50.98M	▲ -46.99M	▲ 17.36M	▼ -81.99M	▲ -77.54M	▲ -35.75M
Effect Of Forex Changes On Cash	-1.68M	▲ 5.57M	▲ 5.94M	▼ 751.00K	▼ -115.00K	▲ 15.10M	▼ -3.82M
Net Change In Cash	-29.56M	▲ -23.60M	▲ 73.59M	▼ 8.37M	▲ 16.92M	▲ 72.07M	▼ -24.31M
Cash At End Of Period	266.82M	▼ 246.97M	▲ 304.97M	▼ 122.93M	▲ 142.73M	▲ 224.14M	▼ 199.83M
Cash At Beginning Of Period	296.38M	▼ 270.58M	▼ 231.38M	▼ 114.56M	▲ 125.81M	▲ 152.07M	▲ 224.14M
Operating Cash Flow	104.04M	▲ 134.08M	▲ 188.73M	▼ 104.07M	▲ 172.27M	▲ 219.64M	▼ 92.33M
Capital Expenditure	-66.20M	▲ -55.62M	▼ -74.99M	▼ -91.25M	▲ -84.30M	▲ -83.56M	▲ -75.66M
Free Cash Flow	37.85M	▲ 78.46M	▲ 113.74M	▼ 12.82M	▲ 87.97M	▲ 136.08M	▼ 16.67M
Link	View	View	View	View	View	View	View
Final Link	View	View	View	View	View	View	View